Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q2 2021 · 10-Q
Revenue$69.00K$69.00K+155.6% vs Q2 2020 Net Income-$3.49M-$3.49MN/M vs Q2 2020 EPS Diluted-$0.20-$0.20N/M vs Q2 2020 Operating Income-$3,489,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,893,000N/M Margins · derivedOperating margin-5056.5%+8180.5 pt vs Q2 2020
Net margin-5053.6%+8179.7 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end